Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Abpro, Aikido, Altimmune, Amcure, Aravive, Astrazeneca, Atyr, Biontech, Biovaxys Technology, Bristol Myers Squibb, CCT Research, Collplant, CSL, Curevac, Farmacore, Guangzhou Baiyunshan, Hinova, Hitgen, Immuron, Johnson & Johnson, Kiadis, Lonza, Lung, Mallinckrodt, Nanoviricides, Noxopharm, Origimed, PDS, Pfizer, Pluristyx, Prestige, Qiagen, Recce, Reven, Selva, Sumitomo Dainippon, Sumitovant, Taiho, Takeda, Teva, Tscan, Urovant Sciences, Vaxart, Wuxi Advanced, Wuxi Apptec, Xoma, Xortx.